Improving how well the body absorbs certain medications taken by mouth.
Novel Formulation Technology to Enhance Oral Absorption of Water-insoluble Drugs
This study is working on a new way to make certain medications easier for your body to absorb, so you can get better results from your treatment with possibly lower doses.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of North Texas Hlth Sci Ctr NIH-funded |
| Lab location | 1 site (Fort Worth, United States) |
| Project ID | NIH-10792061 on NIH RePORTER |
What this research studies
This research focuses on developing a new formulation technology aimed at enhancing the oral absorption of drugs that are typically difficult for the body to absorb. By using innovative methods to improve how these medications dissolve and are taken up in the digestive system, the research seeks to make treatments more effective for patients. The approach involves creating formulations that can better interact with water, which is crucial for drug absorption. Patients may benefit from improved medication efficacy and potentially lower doses needed for treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients who require treatment with water-insoluble medications and have experienced issues with absorption.
Not a fit: Patients who are not taking water-insoluble drugs or those who do not require oral medication may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective oral medications for patients with conditions requiring water-insoluble drugs.
How similar studies have performed: Other research has shown promise in improving drug absorption through novel formulation technologies, indicating potential for success in this area.
Where this research is happening
Fort Worth, United States
- University of North Texas Hlth Sci Ctr — Fort Worth, United States (Active)
Researchers
- Principal investigator: Dong, Xiaowei — University of North Texas Hlth Sci Ctr
- Study coordinator: Dong, Xiaowei
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.